Evidence map›Paper›PMID 39844595›Full record

Observational studyHeadache2025

Development of the Migraine-Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study.

Elizabeth K Seng, E Jolanda Muenzel, Robert E Shapiro, Dawn C Buse, Michael L Reed, Anthony J Zagar, Sait Ashina, Susan Hutchinson, Robert A Nicholson, Richard B Lipton

Abstract readObservational Study
In one paragraph

Observational study in Headache, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizabeth K SengDepartment of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0002-8938-4949
E Jolanda MuenzelEli Lilly and Company, Indianapolis, Indiana, USA.ORCID 0009-0000-7929-3704
Robert E ShapiroDepartment of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.ORCID 0000-0002-7401-0514
Dawn C BuseDepartment of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0002-3784-6144
Michael L ReedVedanta Research, Chapel Hill, North Carolina, USA.ORCID 0000-0002-1353-2300
Anthony J ZagarEli Lilly and Company, Indianapolis, Indiana, USA.
Sait AshinaDepartment of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID 0000-0003-3973-6640
Susan HutchinsonOrange County Migraine and Headache Center, Irvine, California, USA.ORCID 0000-0001-6353-2846
Robert A NicholsonEli Lilly and Company, Indianapolis, Indiana, USA.ORCID 0000-0002-2725-9739
Richard B LiptonDepartment of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0003-2652-2897

Funding

Eli Lilly & Company
6 · The paper itself

Abstract

backgroundStigma is emerging as an important social contributor to migraine-related disability and other outcomes. Currently, there are no published validated measures of migraine-specific measures of stigma.

objectivesThis secondary post hoc analysis of a cross-sectional cohort study aimed to develop a questionnaire to evaluate migraine-related stigma.

methodsBased on focus group discussions among persons with migraine and literature review, a panel of migraine experts iteratively developed 12 candidate items for the migraine-related stigma (MiRS) questionnaire, which aims to measure if and how people living with migraine perceive they are viewed in a stigmatizing manner by others. The United States ObserVational survey of the Epidemiology tReatment and Care Of MigrainE (OVERCOME) study identified people with active migraine within a demographically representative United States (US) adult sample and administered the novel MiRS questionnaire in addition to questionnaires assessing sociodemographics, monthly headache days, and migraine disability score (Migraine Disability Assessment) among other data. Exploratory factor analysis was then utilized to evaluate the structure of the MiRS items and determine the Cronbach's alpha described internal consistency of the factors.

resultsThis exploratory factor analysis was a secondary post hoc analysis of a cross-sectional cohort study derived from the OVERCOME population-based web survey, which was conducted in a United States sample of 61,932 adults with migraine. The mean (standard deviation) age was 41.7 (14.8) years, 74.5% (n = 46,122) were female, and 70.3% (n = 43,564) identified as White. Two factors were identified: MiRS-external perception of Secondary Gain (eigenvalue = 21.5, percentage of total variance = 88.9%) and MiRS-external perception of Minimizing Burden of migraine (eigenvalue = 2.7, percentage of total variance = 11.1%). The two factors were correlated (r = 0.66) and a non-orthogonal varimax rotation showed that eight items loaded onto the MiRS-Secondary Gain factor, and four items loaded onto the MiRS-Minimizing Burden factor.

conclusionThis population-based study of >60,000 people with migraine allowed the development and validation of the first migraine-specific measure of perceived external stigma for people with migraine. This study demonstrated that MiRS consists of two internally consistent subscales: Secondary Gain and Minimizing Burden. This may be a useful tool for quantifying perceived migraine-related stigma to understand determinants of migraine-related stigma and test interventions to reduce perceived migraine-related stigma.

Indexed as

Migraine DisordersPsychometricsSocial StigmaAdultCohort StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedSurveys and QuestionnairesUnited Statesdisabilityinterictal burdenmigrainequality of lifestigma

Identifiers

PMID39844595
PMCPMC11794965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.